Valproate Induced Hyperammonemic Encephalopathy

J Ayub Med Coll Abbottabad. 2022 Oct-Dec;34(Suppl 1)(4):S1038-S1039. doi: 10.55519/JAMC-04-S4-10190.

Abstract

Valproate is a commonly prescribed anticonvulsant drug. It has a potential to cause hyperammonemia even in the presence of normal liver function tests. This hyperammonemic state can lead to encephalopathy referred as Valproate induced hyperammonemic encephalopathy (VHE). Here we present a case of valproate induced hyperammonemic encephalopathy in a young male caused by initiation of valproate therapy.

Keywords: Neurology; Valproate; Encephalopathy.

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / adverse effects
  • Brain Diseases* / chemically induced
  • Humans
  • Hyperammonemia* / chemically induced
  • Hyperammonemia* / drug therapy
  • Male
  • Neurotoxicity Syndromes* / drug therapy
  • Neurotoxicity Syndromes* / etiology
  • Valproic Acid / adverse effects

Substances

  • Valproic Acid
  • Anticonvulsants